Found: 11
Select item for more details and to access through your institution.
Current and Emerging Classes of Pharmacological Agents for the Management of Hypertension.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 271, doi. 10.1007/s40256-021-00510-9
- By:
- Publication type:
- Article
Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombi.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 231, doi. 10.1007/s40256-021-00509-2
- By:
- Publication type:
- Article
Correction to: Perindopril/Indapamide/Amlodipine in Hypertension: A Profile of Its Use.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 299, doi. 10.1007/s40256-022-00528-7
- By:
- Publication type:
- Article
SGLT-2 Inhibitors on Top of Current Pharmacological Treatments for Heart Failure: A Comparative Review on Outcomes and Cost Effectiveness.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 263, doi. 10.1007/s40256-021-00508-3
- By:
- Publication type:
- Article
Dapagliflozin Versus Sacubitril–Valsartan to Improve Outcomes of Patients with Reduced Ejection Fraction and Diabetes Mellitus.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 325, doi. 10.1007/s40256-021-00506-5
- By:
- Publication type:
- Article
Improving the Management of Hypertension by Tackling Awareness, Adherence, and Clinical Inertia: A Symposium Report.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 251, doi. 10.1007/s40256-021-00505-6
- By:
- Publication type:
- Article
De-escalation from Prasugrel or Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome Managed with Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Clinical Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 287, doi. 10.1007/s40256-021-00504-7
- By:
- Publication type:
- Article
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 333, doi. 10.1007/s40256-021-00501-w
- By:
- Publication type:
- Article
Real-World Effectiveness of Ivabradine in Chinese Patients with Chronic Heart Failure: Interim Analysis of the POSITIVE Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 345, doi. 10.1007/s40256-021-00500-x
- By:
- Publication type:
- Article
Is it Time for Single-Pill Combinations in Dyslipidemia?
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 3, p. 239, doi. 10.1007/s40256-021-00498-2
- By:
- Publication type:
- Article